The Development of a Weighted Index to Optimise Compound Libraries for High Throughput Screening

被引:36
作者
Eurtivong, Chatchakorn [1 ]
Reynisson, Johannes [2 ]
机构
[1] Chulabhorn Grad Inst, Chem Biol, 54 Kamphaeng Phet 6 Rd, Bangkok 10210, Thailand
[2] Univ Auckland, Sch Chem Sci, Private Bag 92019, Auckland 1142, New Zealand
关键词
Physicochemical properties; Bioavailability; Known drug space; Hit and Leads; DRUG DISCOVERY; FORCE-FIELD; SPECIFICITY; SPACE; STATE; SIZE;
D O I
10.1002/minf.201800068
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
1880 known drugs were collected and analysed for their mainstream molecular descriptors: MW, log P, HA, HD, RB and PSA. The statistical distributions were fitted to Gaussian functions for each of the descriptors. This gave a mathematical tool to calculate a weighted score, or an Index, for each descriptor. Known Drug Indexes (KDIs) were derived either by summation or multiplication of the Indexes, giving one number for each molecule calculated. The KDI summation and multiplication methods give a theoretical maxima of 6 and 1 respectively. According to both methods, methysergide (5.89/0.90), amsacrine (5.89/0.89) and fluorometholone (5.88/0.88) have the scores of the most well-balanced pharmaceuticals. The KDIs are advantageous tools in identifying the most well-balanced screening compounds based on the properties of known drugs; the screening collection can be optimised to only include quality compounds, which in turn produce tractable hit and lead compounds from the screening campaign.
引用
收藏
页数:10
相关论文
共 44 条
[1]   CONFORMATIONAL-ANALYSIS .130. MM2 - HYDROCARBON FORCE-FIELD UTILIZING V1 AND V2 TORSIONAL TERMS [J].
ALLINGER, NL .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1977, 99 (25) :8127-8134
[2]  
[Anonymous], 2014, AUSTR MED HDB
[3]   Investigation of the incidence of "undesirable" molecular moieties for high-throughput screening compound libraries in marketed drug compounds [J].
Axerio-Cilies, Peter ;
Castaneda, Ivan P. ;
Mirza, Amin ;
Reynisson, Johannes .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (03) :1128-1134
[4]   Characteristics of known drug space. Natural products, their derivatives and synthetic drugs [J].
Bade, Richard ;
Chan, Ho-Fung ;
Reynisson, Johannes .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (12) :5646-5652
[5]  
Bickerton GR, 2012, NAT CHEM, V4, P90, DOI [10.1038/NCHEM.1243, 10.1038/nchem.1243]
[6]   A simple approach for indexing the oral druglikeness of a compound: Discriminating druglike compounds from nondruglike ones [J].
Biswas, Dhrubajyoti ;
Roy, Sujata ;
Sen, Srikanta .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2006, 46 (03) :1394-1401
[7]   Conformational energy penalties of protein-bound ligands [J].
Bostrom, J ;
Norrby, PO ;
Liljefors, T .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1998, 12 (04) :383-396
[8]   The impact of carbon-hydrogen bond dissociation energies on the prediction of the cytochrome P450 mediated major metabolic site of drug-like compounds [J].
Drew, Kurt L. M. ;
Reynisson, Johannes .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 56 :48-55
[9]   Size estimation of chemical space: how big is it? [J].
Drew, Kurt L. M. ;
Baiman, Hakim ;
Khwaounjoo, Prashanna ;
Yu, Bo ;
Reynisson, Johannes .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2012, 64 (04) :490-495
[10]  
Erhlich PaulR., 2014, Ethics in Science and Environmental Politics, V14, P11, DOI [https://doi.org/10.3354/esep00151, DOI 10.3354/ESEP00151]